IGEA Pharma NV is a holding company that aims to improve human health through innovative technologies and solutions based in Hoofddorp, The Netherlands, listed at SIX in Zurich, Switzerland. It combines the expertise to transform natural resources into functional food, food supplements and high-tech products for the cosmetic and pharma industries, with the expertise in health-tech and med-tech products and devices. Its development, production and commercialization entities currently include locations in Italy, Switzerland and the United States. The current focus of the group’s companies includes: - health prevention and nutraceutical solutions with focus on hemp, policosanol and ikuvia extracts based on CO2 supercritical extraction - preventative health-tech products for Alzheimer’s and diabetes - med-tech products for air and inanimate environmental surface sanitization with aerosol technology-based devices
| Website | https://www.igeapharma.nl |
| Ticker | IGPH |
| Revenue | $6000 |
| Employees | View employees |
| Address | 17 Siriusdreef, Hoofddorp 2132 WT, NL |
| Phone | +31 23 568 9494 |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering |
| Competitors | AstraZeneca, Novartis, Pfizer, Bristol Myers Squibb, Roche, Sanofi, Merck & Co., Inc., AbbVie, Lilly India, Johnson & Johnson +37 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular IGEA Pharma N.V. employee's phone or email?
IGEA Pharma N.V. Questions
The IGEA Pharma N.V. annual revenue was $6000 in 2026.
The NAICS codes for IGEA Pharma N.V. are [32541, 325, 3254, 32].
The SIC codes for IGEA Pharma N.V. are [28, 283].
Related Companies
